Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 563

1.

Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.

Miller RG, Block G, Katz JS, Barohn RJ, Gopalakrishnan V, Cudkowicz M, Zhang JR, McGrath MS, Ludington E, Appel SH, Azhir A, Katz J, Kushner G, Wong C, Engel M, Forshew D, Osborne R, Schug B, Akers A, Brent B, Zayas-Bazan T, McCoy S, Goyal N, Harris W, Gonella M, Brooks BR, Bravver E, Sanjak M, Ward AL, Mehrizi A, Belfiore M, Lary C, Nemeth J, Conway J, Bender R, Holsten S, Shue J, Mitsumoto H, Youngman R, Armstrong N, Lee YW, Weimer LH, Brannagan T 3rd, Hirano M, Scotto M, Dalton K, Bedlack RS, Morgenlander JC, Boyette CL, Grace KL, Arvik BM, Thomas Hickey P, Lasater Scott B, Lynn Heydt D, Perry-Trice P, Cudkowicz M, Berry J, Atassi N, Boylan K, Kennelly K, DeSaro P, Johnston A, Huser A, Fuqua P, Staggs K, Babcock L, Kryston T, Ross MA, Bosch EP, Verheijde JL, Grover Y, Duffy AK, Lee MS, McLaughlin RR, Musil DJ, Early J, Whiteman D, Wisbey JA, Simpson EP, Pleitez MY, Lay LF Jr, Halton SL, Schwartz T, Blanton L, Lai EC, Pioro EP, Kuenzler R, Berry N, Khan S, Chowdhury N, Biernot J, Goslin K, Carter GT, Corkrey PM, Ann Kovarik M, Shefner JM, Simionescu L, Grosso M, Watson ML, Reale MA, Duleep A, Carhart R, Markis K, Money K, Boevin T, Lava N, Glass JD, Polak M, Shaw L, Bordeau J, Rogers S, Ferguson S, Fournier C, Kelly C, Mozaffar T, Wang AK, Ramsey G, Tully PA, Graves M, Wiedau-Pazos M, Alvarez R, Barohn R, McVey AL, Dimachkie MM, Pasnoor M, Herbelin L, Walsh M, Kasarskis EJ, Dotson WF, Sitzlar SC, Tandy T, Carrico J, Phillips S, Rice L, Holbrook KM, Eckmann D, Chamblin L, Townsend J, Kaenzig J, Hanley-Borgia L, Vanderpool KE, Taylor DG, Carpenter J, Thomas S, Hutchinson J, King JT.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 9;2(3):e100. doi: 10.1212/NXI.0000000000000100. eCollection 2015 Jun.

2.

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.

Danese MD, Halperin M, Lowe KA, Bradbury BD, Do TP, Block GA.

Nephrol Dial Transplant. 2015 Mar 27. pii: gfv034. [Epub ahead of print]

3.

A randomized, double-blind, phase 2 study evaluating the safety and efficacy of AMG 416 for the treatment of secondary hyperparathyroidism in hemodialysis patients.

Bell G, Huang S, Martin KJ, Block GA.

Curr Med Res Opin. 2015 May;31(5):943-52. doi: 10.1185/03007995.2015.1031731.

PMID:
25786369
4.

Lead ammunition.

Block G.

J Am Vet Med Assoc. 2015 Feb 1;246(3):283. No abstract available.

PMID:
25730918
5.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; for the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 Feb 20. pii: CJN.07730814. [Epub ahead of print]

PMID:
25710802
6.

A Fully Automated Diabetes Prevention Program, Alive-PD: Program Design and Randomized Controlled Trial Protocol.

Block G, Azar KM, Block TJ, Romanelli RJ, Carpenter H, Hopkins D, Palaniappan L, Block CH.

JMIR Res Protoc. 2015 Jan 21;4(1):e3. doi: 10.2196/resprot.4046.

7.

Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.

Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD, Block GA, Collins AJ.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414. Epub 2014 Dec 16.

8.

Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Dehmel B, Goodman WG, Drüeke TB; for the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

J Am Soc Nephrol. 2014 Dec 11. pii: ASN.2014040414. [Epub ahead of print]

PMID:
25505257
9.

A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5.

Block GA, Fishbane S, Rodriguez M, Smits G, Shemesh S, Pergola PE, Wolf M, Chertow GM.

Am J Kidney Dis. 2015 May;65(5):728-36. doi: 10.1053/j.ajkd.2014.10.014. Epub 2014 Nov 4.

10.

Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis.

Mathew AT, Hazzan A, Jhaveri KD, Block GA, Chidella S, Rosen L, Wagner J, Fishbane S.

Am J Nephrol. 2014;40(5):451-7. doi: 10.1159/000369039. Epub 2014 Nov 26.

PMID:
25427771
11.

Sodium zirconium cyclosilicate in hyperkalemia.

Packham DK, Rasmussen HS, Lavin PT, El-Shahawy MA, Roger SD, Block G, Qunibi W, Pergola P, Singh B.

N Engl J Med. 2015 Jan 15;372(3):222-31. doi: 10.1056/NEJMoa1411487. Epub 2014 Nov 21.

PMID:
25415807
12.

Tip-toeing toward the finish line.

Block G, Isakova T.

Nephrol Dial Transplant. 2015 Jan;30(1):1-3. doi: 10.1093/ndt/gfu360. Epub 2014 Nov 20. No abstract available.

PMID:
25414374
13.

Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.

Wheeler DC, London GM, Parfrey PS, Block GA, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Kubo Y, Mahaffey KW, Goodman WG, Moe SM, Trotman ML, Abdalla S, Chertow GM, Herzog CA; EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Investigators.

J Am Heart Assoc. 2014 Nov 17;3(6):e001363. doi: 10.1161/JAHA.114.001363.

14.

Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study.

Ix JH, Anderson CA, Smits G, Persky MS, Block GA.

Am J Clin Nutr. 2014 Nov;100(5):1392-7. doi: 10.3945/ajcn.114.085498. Epub 2014 Aug 27.

PMID:
25332338
15.

NP001 regulation of macrophage activation markers in ALS: a phase I clinical and biomarker study.

Miller RG, Zhang R, Block G, Katz J, Barohn R, Kasarskis E, Forshew D, Gopalakrishnan V, McGrath MS.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):601-9. doi: 10.3109/21678421.2014.951940. Epub 2014 Sep 5.

PMID:
25192333
16.

Dietary guideline adherence for gastroesophageal reflux disease.

Kubo A, Block G, Quesenberry CP Jr, Buffler P, Corley DA.

BMC Gastroenterol. 2014 Aug 14;14:144. doi: 10.1186/1471-230X-14-144.

17.

Volume and type of alcohol during early pregnancy and the risk of miscarriage.

Avalos LA, Roberts SC, Kaskutas LA, Block G, Li DK.

Subst Use Misuse. 2014 Sep;49(11):1437-45. doi: 10.3109/10826084.2014.912228. Epub 2014 May 8.

PMID:
24810392
18.

Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation.

Robinson-Cohen C, Ix JH, Smits G, Persky M, Chertow GM, Block GA, Kestenbaum BR.

J Ren Nutr. 2014 May;24(3):194-9. doi: 10.1053/j.jrn.2014.02.001.

PMID:
24759300
19.

Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4.

Kiu Weber CI, Duchateau-Nguyen G, Solier C, Schell-Steven A, Hermosilla R, Nogoceke E, Block G.

Clin Kidney J. 2014 Apr;7(2):167-173. Epub 2014 Mar 9.

20.

Total pancreatectomy and islet autotransplantation in chronic pancreatitis: recommendations from PancreasFest.

Bellin MD, Freeman ML, Gelrud A, Slivka A, Clavel A, Humar A, Schwarzenberg SJ, Lowe ME, Rickels MR, Whitcomb DC, Matthews JB; PancreasFest Recommendation Conference Participants, Amann S, Andersen DK, Anderson MA, Baillie J, Block G, Brand R, Chari S, Cook M, Cote GA, Dunn T, Frulloni L, Greer JB, Hollingsworth MA, Kim KM, Larson A, Lerch MM, Lin T, Muniraj T, Robertson RP, Sclair S, Singh S, Stopczynski R, Toledo FG, Wilcox CM, Windsor J, Yadav D.

Pancreatology. 2014 Jan-Feb;14(1):27-35. doi: 10.1016/j.pan.2013.10.009. Epub 2013 Nov 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk